Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Operating Segments (Tables)

v3.7.0.1
Note 10 - Operating Segments (Tables)
6 Months Ended
Jun. 30, 2017
Notes Tables  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
   
Treatment
   
Services
   
Medical
   
Segments
Total
   
Corporate
(1)
   
Consolidated
Total
 
Revenue from external customers
  $
9,630
    $
3,085
     
    $
12,715
    $
    $
12,715
 
Intercompany revenues
   
97
     
7
     
     
104
     
     
 
Gross profit
   
2,174
     
180
     
     
2,354
     
     
2,354
 
Research and development
   
62
     
     
550
     
612
     
7
     
619
 
Interest income
   
     
     
     
     
36
     
36
 
Interest expense
   
(18
)    
     
     
(18
)    
(72
)    
(90
)
Interest expense-financing fees
   
     
     
     
     
(9
)    
(9
)
Depreciation and amortization
   
988
     
135
     
     
1,123
     
10
     
1,133
 
Segment income (loss) before income taxes
   
1,238
     
(553
)    
(550
)    
135
     
(1,295
)    
(1,160
)
Income tax expense
   
65
     
     
     
65
     
1
     
66
 
Segment income (loss)
   
1,173
     
(553
)    
(550
)    
70
     
(1,296
)    
(1,226
)
Expenditures for segment assets
   
91
     
3
     
     
94
     
     
94
 
   
Treatment
   
Services
   
Medical
   
Segments
Total
   
Corporate
(1)
   
Consolidated
Total
 
Revenue from external customers
  $
7,985
 
 
$
6,824
     
    $
14,809
    $
    $
14,809
 
Intercompany revenues
   
6
 
 
 
10
     
     
16
     
     
 
Gross profit
   
582
 
 
 
1,234
     
     
1,816
     
     
1,816
 
Research and development
   
120
 
 
 
7
     
416
     
543
     
11
     
554
 
Interest income
   
2
 
 
 
     
     
2
     
29
     
31
 
Interest expense
   
(14
)
 
 
     
     
(14
)    
(94
)    
(108
)
Interest expense-financing fees
   
 
 
 
     
     
     
(29
)    
(29
)
Depreciation and amortization
   
705
 
 
 
160
     
     
865
     
47
     
912
 
Segment (loss) income before income taxes
   
(10,557
)
(2)
 
1,046
     
(416
)    
(9,927
)    
(1,374
)    
(11,301
)
Income tax benefit
   
(3,167
)
(2)
 
     
     
(3,167
)    
     
(3,167
)
Segment (loss) income
   
(7,390
)
 
 
1,046
     
(416
)    
(6,760
)    
(1,374
)    
(8,134
)
Expenditures for segment assets
   
16
 
 
 
4
     
     
20
     
     
20
 
   
Treatment
   
Services
   
Medical
   
Segments
Total
   
Corporate
(1)
   
Consolidated
Total
 
Revenue from external customers
  $
19,665
    $
5,757
     
    $
25,422
    $
    $
25,422
 
Intercompany revenues
   
113
     
10
     
     
123
     
     
 
Gross profit
   
4,861
     
212
     
     
5,073
     
     
5,073
 
Research and development
   
243
     
     
750
     
993
     
15
     
1,008
 
Interest income
   
     
     
     
     
71
     
71
 
Interest expense
   
(26
)    
(1
)    
     
(27
)    
(162
)    
(189
)
Interest expense-financing fees
   
     
     
     
     
(18
)    
(18
)
Depreciation and amortization
   
1,997
     
271
     
     
2,268
     
20
     
2,288
 
Segment income (loss) before income taxes
   
2,840
     
(1,260
)    
(750
)    
830
     
(2,584
)    
(1,754
)
Income tax expense
   
145
     
     
     
145
     
2
     
147
 
Segment income (loss)
   
2,695
     
(1,260
)    
(750
)    
685
     
(2,586
)    
(1,901
)
Expenditures for segment assets
   
106
     
10
     
     
116
     
     
116
 
   
Treatment
   
Services
   
Medical
   
Segments
Total
   
Corporate
(1)
   
Consolidated
Total
 
Revenue from external customers
  $
15,189
 
 
$
9,658
     
    $
24,847
    $
    $
24,847
 
Intercompany revenues
   
10
 
 
 
15
     
     
25
     
     
 
Gross profit
   
444
 
 
 
1,406
     
     
1,850
     
     
1,850
 
Research and development
   
226
 
 
 
33
     
854
     
1,113
     
15
     
1,128
 
Interest income
   
2
 
 
 
     
     
2
     
45
     
47
 
Interest expense
   
(16
)
 
 
     
     
(16
)    
(260
)    
(276
)
Interest expense-financing fees
   
 
 
 
     
     
     
(85
)    
(85
)
Depreciation and amortization
   
1,418
 
 
 
321
     
     
1,739
     
57
     
1,796
 
Segment (loss) income before income taxes
   
(11,805
)
(2)
 
322
     
(854
)    
(12,337
)    
(2,773
)    
(15,110
)
Income tax benefit
   
(3,130
)
(2)
 
     
     
(3,130
)    
     
(3,130
)
Segment (loss) income
   
(8,675
)
 
 
322
     
(854
)    
(9,207
)    
(2,773
)    
(11,980
)
Expenditures for segment assets
   
23
 
 
 
4
     
1
     
28
     
     
28